"These new studies are the latest examples of how our whole-transcriptome-based Afirma GRID research tool is helping to advance our collective understanding of thyroid cancer at the molecular level," ...

Inoviq has issued a lengthy response to the ASX's'please explain' pertaining to the company's early-stage cancer work. ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

The deadline to submit abstracts for scientific posters for the IAEA’s International Conference on Radiation Protection in Medicine — X Ray Vision to be hosted in Vienna, Austria from 8 to 12 December ...

Authors: Thomas Wallach, Mihaela Ringheanu, Ana Roig Cantisano, Yang Yang, Karishma Raju, Jocelyn Tabora, Susan Edelstein Poster Number: Sa1643 Date/Time: May 3, 2025, from 12:30 PM to 1:30 PM PDT ...

WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...

Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence ...

Interested contributors have until 2 May 2025 to submit abstracts for scientific posters for the IAEA’s International Conference on Radiation Protection in Medicine — X Ray Vision. The conference, ...

Posters will be hung up by the curriculum office on Wednesday, March 5 and will stay until 2 p.m., Thursday, March 6, 2025. Each presentation board will be labeled with a number and a category that ...